novo tirzepatide Nordisk shares down after analysis finds Lilly drug leads to better weight loss Lilly's tirzepatide and Novo Nordisk's

GLP-1 is a medication that helps regulate appetite

If you have risk factors or these symptoms, your doctor may recommend testing for vitamin B12 deficiency

Key takeaways: Estrogen is a hormone that turns on or off the transcription of estrogen-responsive genes, many of which are involved in cell growth

doi: 10.1016/j.bbi.2024.03.019 94

Ready to take your expertise in medical weight loss to the next level

Survodutide Timeline Boehringer Ingelheims SYNCHRONIZE program includes multiple Phase 3 trials: SYNCHRONIZE-1: Obesity without type 2 diabetes (726 participants, 76 weeks) SYNCHRONIZE-2: Obesity with type 2 diabetes (755 participants, 76 weeks) SYNCHRONIZE-CVOT: Cardiovascular outcomes (4,935 participants target) LIVERAGE trials: MASH-specific studies initiated October 2024 FDA Breakthrough Therapy designation for MASH may accelerate review for that indication specifically